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Methods Patients randomized into the Asymptomatic Carotid Atherosclerosis Study (ACAS) underwent a neurological history, a detailed stroke/transient ischemic attack questionnaire, and a detailed neurological examination. Computed tomography scans were examined by standardized criteria developed as part of a quality-control program supervised by a neuroradiologist. The presence, location, and size of all cerebral infarctions evident by computed tomography were determined.
Results Among 1132 patients, 848 had no history of stroke or transient ischemic attack. One hundred twenty-six patients (15%) had a silent infarct; 95 (11%) had one, 24 (3%) had two, W ith the development of high-resolution brain imaging, the limitations of the neurological history and examination in identifying brain pathology have become increasingly apparent. Today the diagnosis of transient ischemic attack (TIA) may be associated with imaging evidence for cerebral infarction by brain computed tomography (CT) '-7 or by magnetic resonance imaging (MRI). 8 Thus the imaging diagnosis of cerebral infarction is increasingly made for patients evaluated by CT or MRI in the absence of typical symptoms or signs of stroke (eg, patients evaluated for dementia or headache).
The Asymptomatic Carotid Atherosclerosis Study (ACAS) 9 is a multicenter, randomized trial comparing carotid endarterectomy plus medical therapy with medical therapy alone for treatment of hemodynamically significant but asymptomatic carotid artery stenosis. We believe this cohort is at high risk for symptomatic ischemic stroke and hypothesized that the cohort may also be at high risk for asymptomatic, "silent" stroke. We report the baseline CT scan characteristics obtained for patients enrolled in the ACAS trial without a history of stroke. The number, size, and location of the silent cerebral infarcts are described. The potential relations of silent cerebral infarction to stroke risk factors, the neurological examination, and the degree of carotid stenosis are addressed.
Subjects and Methods
ACAS is a multicenter, randomized trial of carotid endarterectomy for asymptomatic, hemodynamically significant carotid artery stenosis. Patient enrollment ended in December 1993. To be eligible, patients had to be between the ages of 40 and 79 years and had to have a unilateral or bilateral surgically accessible stenosis of the common or internal carotid artery of at least 60% (determined by criteria that have been previously described).
9 ' 10 A TIA/stroke questionnaire was administered to each patient to supplement the neurological history and standardized neurological examination." Patients were also given the Folstein Mini-Mental Status test. Candidates did not qualify if a history of TIA or stroke ipsilateral to the study artery was detected or if a history of vertebrobasilar distribution TIA or stroke was detected. Other exclusions were serious cardiac, respiratory, or neoplastic disease that would limit survival to 5 years or less; focal seizures within the last 2 years; confounding neurological illness causing transient deficits; uncontrolled hypertension; warfarin use; previous ipsilateral carotid surgery or cervical region radiation; intolerance for aspirin; other factors that could be contraindications for surgery or prevent 5-year follow-up; and confounding major neurological examination abnormalities in the distribution of the ACAS artery (eg, a patient with cerebral palsy was not eligible if a major hemiparesis was present, ipsilateral to the ACAS artery, but was eligible if the hemiparesis was modest).
Each patient randomized into ACAS underwent brain CT examination at baseline and will have another CT at the time of any end point and at the time of study exit. The baseline CT scans were obtained after the neurological histories and examinations were carried out and after randomization, except in those circumstances where a CT had been performed within 3 months before randomization and was available for analysis. A CT lesion played no role in eligibility or randomization. The CT examinations were noncontrast and followed similar but not identical imaging protocols. For the most part, the CT examinations were performed with 10-mm slice thickness reconstructed on a 512x512 matrix with 15° orbital-meatal angle slices; a window level of 50 and a window width of 100 Hounsfield units were used.
Silent infarcts were defined as any circumscribed low attenuation consistent with cerebral infarction (ie, infarct by CT) occurring in any cerebral location in patients without a history of stroke. The vascular distribution of each infarct was determined after the method of Damasio, 12 and arterial distribution templates were used. For a qualitative estimate of lesion volume, a cerebral lobe was used as the unit of measurement. Lesions were then subdivided into four categories: small and deep, less than one-half lobe, up to one lobe, and larger than one lobe. Lesion size was also assessed by an estimate of the volume of low attenuation by CT.
A CT quality-control program was carried out to attain a degree of uniformity in the readings. Before the beginning of recruitment, each center received five scans, chosen to include some difficult or potentially ambiguous diagnostic problems. The readings from the centers were then compared with those of the study neuroradiologist (T.T.). Potential reasons for disagreement were communicated to the local center reader. In addition to this initial test, ongoing monitoring continues. The CT scan films and completed CT scan forms for the first five randomized patients from each center were submitted to the central neuroradiologist for blind rereading. Again, potential explanations for disagreements were determined by the central neuroradiologist and communicated to the local reader. This process was repeated 1 year after a center began recruitment as well as on three additional occasions.
The results from the CT quality-control program and from the baseline CT scan readings were analyzed at the ACAS Statistical Coordinating Center. A x 2 t e s t was used when all of the cell sizes in the 2x2 table were 10 or greater. When any cell size was less than 10, a Fisher's exact test was used instead. All tests were two sided, and significance was declared when the rounded probability value was less than .05. No adjustments for multiple comparisons were made.
Results
Characteristics of the ACAS population with no history of stroke or TIA are summarized in Table 1 . Approximately two thirds of the patients were men, younger than age 70, or had a history of hypertension. Only 95 of the patients (11%) were taking aspirin. A lipid disturbance (defined as total cholesterol levels >240 mg/dL, low-density lipoprotein >160 mg/dL, high-density lipoprotein <35 mg/dL, or triglyceride levels >200 mg/dL) was present in 721 patients (88%).
The quality-control comparison of the local center CT reading with the central reading was completed for 342 patients. In 37 cases (10.8%) there was disagreement as to whether a stroke was seen on the CT film. Under the assumption that the readings of the ACAS 412 (49) 543 (64) 312 (37) 562 (70) 208 (24) 311 (37) 49 (6) 721 (88) 214 (25) 95 (11) 175 (21) 296 (35) ACAS indicates Asymptomatic Carotid Atherosclerosis Study. *Number of patients with sufficient data to identify the characteristics.
central neuroradiologist define the "gold standard," the sensitivity of the local CT readings was 69%, the specificity was 95%, the positive predictive value was 82%, and the negative predictive value was 91%.
Eleven hundred thirty-two patients had valid CT scans. Of these, 141 patients had a previous contralateral stroke, and an additional 139 patients had a contralateral TIA. For 248 patients, one or more lesions were seen on CT. The proportion of patients with such lesions increased dramatically with severity of disease from asymptomatic (15% had lesions) to TIA (25%) to stroke (62%). The overall test for trend was highly significant (P<.001) as were all pairwise comparisons among stroke, TIA, and asymptomatic groups (P<.01 for all). For 85% (75/88) of the stroke patients with lesions, at least one lesion occurred on the symptomatic side. However, for only 56% (19/34) of the TIA patients did the lesion occur on the symptomatic side.
The size of the lesion(s) also increased as severity progressed from asymptomatic to TIA to stroke. Given that a patient had one or more lesions (of known size), the percentage of such patients with a lesion larger than small and deep was 31% (39/125) of asymptomatic patients, 44% (15/34) of patients with TIA, and 61% (54/88) of stroke patients.
When the analysis was restricted to the 848 completely asymptomatic patients (those without TIA or stroke), at least one silent infarction was identified in 126 patients (15%, Table 2 ): one infarct was identified in 95 (11%), two infarcts were identified in 24 (3%), and three or more infarcts were identified in 7 (1%). Among the 140 silent infarcts for which the vascular distribution was identified, 130 (93%) were located in the carotid territory ( Table 3 ). The frequency of silent infarction was not higher in the distribution of the ACAS artery. Silent infarction was more frequent in the right hemisphere (84 right versus 59 left, />=.05). The silent infarcts were small in size (Table 4) . None was larger than one cerebral lobe, with 72% characterized as small and deep and 28% characterized as less than one-half lobe. Men were somewhat more likely than women to have a silent infarction (16% versus 12%), but significance was borderline (P=.O61; Table  5 ). None of the risk factors for stroke that were analyzed (Table 1) were associated with silent infarction. Persons with gait abnormalities and persons with plantar or deep tendon reflex abnormalities had higher rates of silent lesions (P<.001, P=.O38, respectively). The presence of silent infarction was also associated with abnormal funduscopic examination (P=.OO2), abnormal hear- ing (/>=.O16), abnormal eye movements (P=.O22), and abnormal visual fields (P=.O51).
Among the neurological examination abnormalities, dysphasia, abnormal visual fields, abnormal facial sensation, abnormal facial movement, abnormal sensory examination of the extremities, motor system weakness, and hyperflexia could be lateralized in a meaningful fashion (Table 6 ). Of 833 patients with complete data from these examinations (out of 848), 190 patients had such abnormalities, 30 patients appropriate only to the hemisphere ipsilateral to the ACAS artery and 43 appropriate only to the hemisphere contralateral to the ACAS artery. All of the remaining 117 patients had one or more abnormalities on both sides. Among the 126 silent infarct patients, 121 had complete examination data. Twenty-nine had an abnormality on one or more of these examinations, four appropriate only to the hemisphere ipsilateral to the ACAS artery and six appropriate only to the hemisphere contralateral to the ACAS artery. The remaining 19 patients had abnormalities on both sides.
There was a total of 46 lesions among 39 asymptomatic patients having one or more lesions larger than small and deep. A large lesion was slightly more likely to be detected in the left hemisphere and on the side contralateral to the ACAS randomized artery (not significant). Excluding patients with only small, deep lesions, an analysis of asymptomatic patients indicated an association of larger lesions with abnormalities in cerebellar function (2/8 versus 37/837; P=.O49) and in abnormal plantar/deep tendon reflexes (13/163 versus 26/675; P=.025) .
The ACAS population was subdivided by category of carotid artery stenosis (Table 7) . By ultrasound or angiographic criteria, 9 384 patients (46%) had at least one carotid artery with stenosis of 80% or more, 63 (7%) had both carotid arteries with stenosis of 80% or more, and 49 (6%) had carotid occlusion contralateral to the study artery. No association between the occurrence of silent infarction and the category of unilateral or bilateral stenosis was detected. Carotid occlusion did not increase the risk of silent infarction. A logistic regression analyzing silent infarction by continuous degree of stenosis was not possible because angiography was required only for patients randomized to surgery.
Discussion
Silent cerebral infarction is not rare in populations at increased risk for stroke. Among the patients in ACAS with at least 60% carotid artery stenosis, 15% of those (15) 62 (14) 90 (17) 36 (12) 49 (16) 77 (14) 89 (16) 33 (14) 33 (16) 93 (14) 51 (16) 75 (14) 7 (14) 119 (15) 104 (14) 16 (17) 32 (15) 94 (15) 14 (15) 112 (15 with no history of stroke had a silent infarct identified by CT in either the carotid or the vertebrobasilar distributions. Of those patients, one fourth had more than one infarct. Risk factors for stroke were not more common in patients with silent infarction compared with those without. While prevalence of silent infarction was high in the ACAS population, incidence has yet to be determined. However, exit CT scans are to be performed on all surviving patients at the end of the trial, so we will eventually be able to determine the incidence for the ACAS population.
In other studies of patients with asymptomatic carotid atherosclerosis reporting on patient samples from 12 to 107 patients, the rate of silent cerebral infarction by CT has ranged from 6% to 28%. 1319 In patients with and without cerebral symptoms studied by CT before carotid endarterectomy, the rate of silent infarction has ranged from 13% to 18%. 1317 In the setting of chronic atrial fibrillation, silent cerebral infarction has been reported in 11% to 48%. 7 -20 -24 In patients with a history of transient ischemic attacks or amaurosis fugax, the rate of silent cerebral infarction has ranged from 0% to 35%'-7 and may be higher among those with vertebrobasilar TIAs. 25 In patients with a history of cerebral infarction, the rate of silent infarction identified by CT was 33% in an Italian stroke population, 26 10% in the Framingham stroke population, 27 and 11% in the Stroke Data Bank population. 28 Even in patients with coronary artery disease, silent cerebral infarction is not infrequent. 19 Silent infarcts in these populations are common. However, compelling evidence that silent infarcts are clinically important is tenuous. Silent infarcts are small lesions. In the ACAS population -to date the largest cohort prospectively examined for silent infarction -72% of the lesions were small and deep, and the remaining 28% were less than one-half cerebral lobe in size. In previous studies, silent infarcts were also small, whether detected in the setting of symptomatic stroke, 2628 TIA, 3 -5 -29 atrial fibrillation, 2022 carotid artery disease, 30 or coronary artery disease. 19 In our cohort, silent infarcts were significantly more frequent in the right hemisphere compared with the left. A potential explanation could be that if symptoms from a small infarct are subtle, they may be more noticeable if language or dominant hand function are affected.
Not only are silent infarcts small, but they have not been linked to significant abnormalities in neurological function. During ACAS enrollment, patients with neurological abnormalities were excluded only if the findings were severe enough to confound evaluation of the hemisphere in the distribution of the ACAS artery. Every ACAS patient was interviewed and examined carefully before randomization and before the CT scan (except in those circumstances where a CT scan performed within the 3 months of randomization was available). Abnormal neurological findings were common, but only abnormalities in gait, deep tendon reflexes or plantar responses, visual fields, funduscopic examination, eye movements, and hearing were associated with silent infarction. However, conclusions cannot be inferred as ACAS was not designed to detect a relation between silent infarction and neurological abnormalities, and statistical adjustments for multiple group comparisons were not made.
Demented patients (Folstein Mini-Mental Status score of less than 20) could not be enrolled in ACAS. However, 15% of the enrolled patients achieved a Folstein Mini-Mental Status score of less than 27. Scores less than 27 were not more common in patients with silent infarction. Similarly, in the Stroke Prevention in Atrial Fibrillation Study, 22 patients with silent stroke did not exhibit a higher frequency of cognitive or functional impairment. An association of dementia with silent infarction was not identified in the Stroke Data Bank population. 28 Only the study by Herderschee and colleagues 29 has shown a relation of silent infarction to lower functional outcome (Rankin scale, grade 1 versus grade 0), but the potential confounding effects of other (15) 24 (14) 91 (15) 35 (14) 52 (18) 74 (13) 3 (16) 123 (15) 6 (32) 120 (14) 14 (30) 106 (14) 5 (42) 120 (14) 3 (27) 123 (15) 19 (24) 107 (14) 20 (14) 103 (15) 7 (15) 118 (15) 2 (25) 124 (15) 13 (35) 111 (14) 33 (20) 93 (14 (14) 14 (17) 4 (33) 6 (18) 42 (19) 2 (4) 5 (12) 1 (6) 1 (17) 
No. (%) of Patients With No Lesions
327 (86) 66 (83) 8 (67) 27 (82) 183 (81) 55 (96) 36 (88) 15 (94) 5 (83 variables more common among those with silent stroke were not examined (ie, age greater than 65 years, hypertension, cigarette smoking). It must be emphasized that none of the studies to date were designed to detect a relationship between dementia and silent infarction. To establish such a relationship, a study must include adequate numbers of patients with and without dementia and adequate numbers of patients with and without silent infarction. Whether silent infarction is a marker for anatomically severe cerebrovascular disease has also not been established. The ACAS cohort is the largest studied prospectively with regard to carotid artery stenosis and silent infarction. No evidence of an association between the degree of stenosis and silent infarction was found. In addition, silent infarcts were just as frequent in the cerebral hemisphere contralateral to the ACAS carotid artery as they were in the ipsilateral hemisphere. Nonetheless, a potential bias against a relation of degree of stenosis to silent infarction was present in that asymptomatic patients could have been excluded if they had preexisting neurological abnormalities ipsilateral to the ACAS (ie, stenosed) artery. Perhaps more important, 71% of the ACAS patients fell into two of eight stenosis categories, and so sample sizes for comparison were very small.
One could hypothesize that because 72% of the ACAS silent infarcts were small and deep, combining all silent infarcts regardless of size could dilute any possible relation of nonlacunar silent infarcts to degree of stenosis. However, when our analysis of silent infarction to stenosis was limited to those with the larger infarctions, no relation was detected. Norris and Zhu, 30 on the other hand, suggest an association between severe stenosis and silent infarction. In a cohort of 381 patients without a history of stroke, 137 had a silent infarction seen by CT, and an increased frequency of silent infarction was noted in the severe stenosis group compared with the mild and moderate stenosis groups (P<.001). The relation was not further explored with multivariate analysis to examine potential confounding variables such as sex and age. A future question to be addressed with the final ACAS results is whether the presence of severe carotid stenosis potentiates the likelihood of small, deep, lacunar-type cerebral infarcts judged clinically to be caused by disease of small, penetrating arteries or arterioles. The baseline ACAS CT results do not directly address the issue, but the small, deep infarcts identified were not more frequent ipsilateral to the more severely stenotic carotid arteries.
TIAs are important markers for anatomic cerebrovascular disease and for the subsequent occurrence of cerebral infarction. In our study as in others, 3 -7 . 293133 the occurrence of TIA has also been associated with silent infarction by CT. Is identifying silent infarction important in identifying patients at high risk for later stroke? In other cohorts studied, the neurological outcome of patients with silent stroke has varied. In the North American Symptomatic Carotid Endarterectomy Trial (NASCET) cohort of 352 TIA patients with highgrade carotid stenosis, 31 silent stroke was present in 121 (34%). Silent stroke was an independent marker for increased subsequent mortality and was an independent marker for increased stroke occurrence in those randomized to the medical group. Evans and colleagues 33 assessed 350 patients with TIAs and found that patients with infarct identified by CT (17%) had significantly shorter survival times. The Dutch TIA Trial Study Group 34 also reported infarct identified by CT to be an independent predictor of vascular death, stroke, or myocardial infarction for patients with TIA. In patients with acute stroke, those with silent stroke have not been more likely than those without to have a less favorable initial outcome 35 or to have an increased rate of recurrent stroke. 2628 In our cohort, we will eventually have 5-year follow-up data on the frequency of subsequent TIA, stroke, and death. 
